FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2071001421> ?p ?o ?g. }

• W2071001421 endingPage "48" @default.
• W2071001421 startingPage "30" @default.
• W2071001421 abstract "Small cell lung cancer (SCLC) is an aggressive type of lung cancer, and the detection of SCLCs at an early stage is necessary for successful therapy and for improving cancer survival rates. Fucosylation is one of the most common glycosylation-based modifications. Increased levels of fucosylation have been reported in a number of pathological conditions, including cancers. In this study, we aimed to identify and validate the aberrant and selective fucosylated glycoproteins in the sera of patients with SCLC. Fucosylated glycoproteins were enriched by the Aleuria aurantia lectin column after serum albumin and IgG depletion. In a narrowed down and comparative data analysis of both label-free proteomics and isobaric peptide-tagging chemistry iTRAQ approaches, the fucosylated glycoproteins were identified as up- or down-regulated in the sera of limited disease and extensive disease stage patients with SCLC. Verification was performed by multiple reaction monitoring-mass spectrometry to select reliable markers. Four fucosylated proteins, APCS, C9, SERPINA4, and PON1, were selected and subsequently validated by hybrid A. aurantia lectin ELISA (HLE) and Western blotting. Compared with Western blotting, the HLE analysis of these four proteins produced more optimal diagnostic values for SCLC. The PON1 protein levels were significantly reduced in the sera of patients with SCLC, whereas the fucosylation levels of PON1 were significantly increased. Fucosylated PON1 exhibited an area under curve of 0.91 for the extensive disease stage by HLE, whereas the PON1 protein levels produced an area under curve of 0.82 by Western blot. The glycan structural analysis of PON1 by MS/MS identified a biantennary fucosylated glycan modification consisting of a core + 2HexNAc + 1Fuc at increased levels in the sera of patients with SCLC. In addition, the PON1 levels were decreased in the sera of the Lewis lung carcinoma lung cancer mouse model that we examined. Our data suggest that fucosylated protein biomarkers, such as PON1, and their fucosylation levels and patterns can serve as diagnostic and prognostic serological markers for SCLC." @default.
• W2071001421 created "2016-06-24" @default.
• W2071001421 creator A5022650882 @default.
• W2071001421 creator A5024801112 @default.
• W2071001421 creator A5025571945 @default.
• W2071001421 creator A5030651366 @default.
• W2071001421 creator A5032439705 @default.
• W2071001421 creator A5033726593 @default.
• W2071001421 creator A5038034025 @default.
• W2071001421 creator A5051435411 @default.
• W2071001421 creator A5051893171 @default.
• W2071001421 creator A5052315121 @default.
• W2071001421 creator A5062884309 @default.
• W2071001421 creator A5075462954 @default.
• W2071001421 date "2014-01-01" @default.
• W2071001421 modified "2023-10-16" @default.
• W2071001421 title "Integrated Glycoproteomics Demonstrates Fucosylated Serum Paraoxonase 1 Alterations in Small Cell Lung Cancer" @default.
• W2071001421 cites W1491212204 @default.
• W2071001421 cites W1583738858 @default.
• W2071001421 cites W1827740955 @default.
• W2071001421 cites W1898563448 @default.
• W2071001421 cites W1972332361 @default.
• W2071001421 cites W1975694462 @default.
• W2071001421 cites W1982704287 @default.
• W2071001421 cites W1983354417 @default.
• W2071001421 cites W1987357522 @default.
• W2071001421 cites W1987640672 @default.
• W2071001421 cites W1993133173 @default.
• W2071001421 cites W1995243908 @default.
• W2071001421 cites W2004125187 @default.
• W2071001421 cites W2013520842 @default.
• W2071001421 cites W2015049954 @default.
• W2071001421 cites W2015556811 @default.
• W2071001421 cites W2016027337 @default.
• W2071001421 cites W2020830322 @default.
• W2071001421 cites W2022034879 @default.
• W2071001421 cites W2025679035 @default.
• W2071001421 cites W2029756930 @default.
• W2071001421 cites W2034762315 @default.
• W2071001421 cites W2052777173 @default.
• W2071001421 cites W2061663562 @default.
• W2071001421 cites W2063901978 @default.
• W2071001421 cites W2065062250 @default.
• W2071001421 cites W2066545420 @default.
• W2071001421 cites W2067136664 @default.
• W2071001421 cites W2068079365 @default.
• W2071001421 cites W2078002244 @default.
• W2071001421 cites W2086142657 @default.
• W2071001421 cites W2091239817 @default.
• W2071001421 cites W2092883299 @default.
• W2071001421 cites W2095395771 @default.
• W2071001421 cites W2112078820 @default.
• W2071001421 cites W2116760479 @default.
• W2071001421 cites W2117946498 @default.
• W2071001421 cites W2124634982 @default.
• W2071001421 cites W2132240438 @default.
• W2071001421 cites W2142923218 @default.
• W2071001421 cites W2146719995 @default.
• W2071001421 cites W2152653388 @default.
• W2071001421 cites W2156062303 @default.
• W2071001421 cites W2323915236 @default.
• W2071001421 cites W2337022581 @default.
• W2071001421 cites W2419001748 @default.
• W2071001421 cites W4300122725 @default.
• W2071001421 doi "https://doi.org/10.1074/mcp.m113.028621" @default.
• W2071001421 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3879622" @default.
• W2071001421 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24085812" @default.
• W2071001421 hasPublicationYear "2014" @default.
• W2071001421 type Work @default.
• W2071001421 sameAs 2071001421 @default.
• W2071001421 citedByCount "74" @default.
• W2071001421 countsByYear W20710014212014 @default.
• W2071001421 countsByYear W20710014212015 @default.
• W2071001421 countsByYear W20710014212016 @default.
• W2071001421 countsByYear W20710014212017 @default.
• W2071001421 countsByYear W20710014212018 @default.
• W2071001421 countsByYear W20710014212019 @default.
• W2071001421 countsByYear W20710014212020 @default.
• W2071001421 countsByYear W20710014212021 @default.
• W2071001421 countsByYear W20710014212022 @default.
• W2071001421 countsByYear W20710014212023 @default.
• W2071001421 crossrefType "journal-article" @default.
• W2071001421 hasAuthorship W2071001421A5022650882 @default.
• W2071001421 hasAuthorship W2071001421A5024801112 @default.
• W2071001421 hasAuthorship W2071001421A5025571945 @default.
• W2071001421 hasAuthorship W2071001421A5030651366 @default.
• W2071001421 hasAuthorship W2071001421A5032439705 @default.
• W2071001421 hasAuthorship W2071001421A5033726593 @default.
• W2071001421 hasAuthorship W2071001421A5038034025 @default.
• W2071001421 hasAuthorship W2071001421A5051435411 @default.
• W2071001421 hasAuthorship W2071001421A5051893171 @default.
• W2071001421 hasAuthorship W2071001421A5052315121 @default.
• W2071001421 hasAuthorship W2071001421A5062884309 @default.
• W2071001421 hasAuthorship W2071001421A5075462954 @default.
• W2071001421 hasBestOaLocation W20710014211 @default.
• W2071001421 hasConcept C104317684 @default.
• W2071001421 hasConcept C108625454 @default.
• W2071001421 hasConcept C135763542 @default.

• next